Latest Healthcare Policy news from across the web.
Advisers to the Food and Drug Administration are backing popular peptide therapies. They voted to allow specialized pharmacies to make them despite agency scientists' recommendations against it.
Read full article →Fifteen years ago, the FDA overhauled its safety rules for fruits and vegetables, hoping to prevent outbreaks of foodborne illness. How's that system working today?
Read full article →Japan's prime minister says she gets just "zero to three hours" of sleep per night. NPR's Michel Martin asks Johns Hopkins' Dr. Sara Benjamin how much sleep most people need to get through the day.
Read full article →The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.
Read full article →Federal health officials are investigating a new outbreak involving the diarrhea-causing parasite cyclospora.
Read full article →The European Medicines Agency is taking what advocacy groups are calling unexpectedly “rapid action” to ensure that clinical trial results are made public as required by law.
Read full article →The Lantus Solostar insulin pen isn't in official FDA shortage, but patients are having a tough time finding it.
Read full article →Too few senators were in attendance to proceed with a vote on the CDC director nominee.
Read full article →Congress is scrambling to advance a slew of health care bills before an August recess. Price transparency and prior authorization top the list.
Read full article →Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."
Read full article →Has a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare disease? Find out on this week's episode of…
Read full article →Sean Kaufman, nominated to run ASPR, has a track record of questioning the safety of vaccines.
Read full article →